ArticleKidney diseases (Basel, Switzerland)
Artificial Intelligence Models in Diagnosis and Treatment of Kidney Diseases: Current Status and Prospects.
Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Development and external validation of an explainable machine learning model for predicting chronic kidney disease progression in the Korean population.Kidney research and clinical practice · 2026Article
- Artificial Intelligence in Nephrology: From Early Detection to Clinical Management of Kidney Diseases.Bioengineering (Basel, Switzerland) · 2025Review
- Ensemble machine learning for predicting renal function decline in chronic kidney disease: development and external validation.Frontiers in medicine · 2025Article
- Guideline Concordance of Chronic Kidney Disease Testing Remains Low in Patients with Diabetes and Hypertension: Real-World Evidence from a City in Northwest China.Kidney diseases (Basel, Switzerland)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Artificial intelligence (AI) has made significant advances in nephrology, revolutionizing the diagnosis, prognosis, and treatment of kidney diseases. Summary: This review provides an overview of AI applications in nephrology, introducing the basic structures of each model, highlighting both traditional machine-learning approaches and neural networks, and providing model application comparisons along with selection recommendations. It discussed key challenges in deciding appropriate AI models for specific tasks and evaluated their advantages, limitations, and optimal use cases. Current applications of AI in nephrology mainly include diagnosis and disease outcome prediction, medical image analysis, treatment recommendations, and personalized health management, supported by massive electronic health records and multimodal data integration. Traditional machine learning models perform well on datasets of varying sizes and structures, while neural networks excel at handling complex and imaging data. Emerging hardware innovations are expected to improve the performance of neural network models, enabling more accurate diagnosis and automated analysis in clinical practice. In the future, AI will have great potential to advance individualized patient care and enable real-time data processing in nephrology. Key Messages: An overview of AI applications in nephrology is provided in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.